Table 3 Relation of early anti-osteoporosis agent prescription with 1-year medical visits and expenditure
|
Patients not on anti-osteoporosis agent (n = 345) |
Patients on anti-osteoporosis agent (n = 233) | p value | ||||
|---|---|---|---|---|---|---|
| Returns for overall medical services (1-year) | ||||||
| Number of patients returned (№) | 283 | (84.6%) | 216 | (88.4%) | < 0.001** | |
| Average expenditure per returned patient (NTD) | 132,500 | ± 258,635 | 111,394 | ± 182,922 | 0.005** | |
| Average expenditure per patient in treatment group (NTD) | 108,688 | ± 239,649 | 103,267 | ± 178,470 | < 0.001** | |
| Returns for outpatient clinic (1-year) | ||||||
| Number of patients returned (№) | 269 | (78.0%) | 208 | (89.3%) | < 0.001** | |
| Average visits per returned patient (times) | 13 | ± 13 | 13 | ± 12 | 0.036* | |
| Average expenditure per returned patient (NTD) | 45,079 | ± 114,539 | 49,585 | ± 70,357 | < 0.001** | |
| Average expenditure per patient in treatment group (NTD) | 35,149 | ± 102,815 | 44,265 | ± 68,215 | < 0.001** | |
| Returns for emergency department (1-year) | ||||||
| Number of patients returned (№) | 91 | (26.4%) | 66 | (28.3%) | 0.673 | |
| Average visits per returned patient (times) | 2 | ± 2 | 2 | ± 2 | 0.332 | |
| Average expenditure per returned patient (NTD) | 21,865 | ± 24,092 | 21,915 | ± 25,536 | 0.957 | |
| Average expenditure per patient in treatment group (NTD) | 5767 | ± 15,652 | 6208 | ± 16,752 | 0.605 | |
| Returns for inpatient admission (1-year) | ||||||
| Number of patients returned (№) | 83 | (24.1%) | 52 | (22.3%) | 0.700 | |
| Average visits per returned patient (times) | 2 | ± 2 | 2 | ± 1 | 0.779 | |
| Average expenditure per returned patient (NTD) | 281,704 | ± 303,361 | 236,559 | ± 243,513 | 0.408 | |
| Average expenditure per patient in treatment group (NTD) | 67,772 | ± 190,991 | 52,794 | ± 150,927 | 0.546 | |